PSI Webinar - Main statistical approaches for quantitative decision-making in drug development
Date: 10th December 2019
Time: 14:00 - 15:30
Speakers: PSI/EFSPI SIG Quantitative Decision-Making members:
- Pierre Colin (Sanofi)
- Juan Abellan (GSK)
- Gaëlle Saint-Hilary (Servier)
Quantitative methods to support decision-making in clinical drug development already exist, but may be unknown or unused by pharmaceutical companies. We performed a survey among pharmaceutical companies, targeting people with different profiles (statisticians, non-statisticians and decision-makers) working at different stages of the clinical development (study level, development level or portfolio level). This survey allowed us to analyze which quantitative methods are known, which quantitative methods are used (or not), what benefit is expected from this kind of methods, and what are the needs for a larger use of quantitative methods to support decision-making. It permitted to understand the gaps and some of the issues associated to the use of such methods in drug development. The webinars are intended to share the learnings from the survey and to promote different quantitative methods for decision-making.
Registration: To register for this free webinar, please click here.
Please email PSI@mci-group.com if you have any questions.